Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
STXS

STXS - Stereotaxis Inc Stock Price, Fair Value and News

$2.49-0.04 (-1.58%)
Market Closed

7/100

STXS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

7/100

STXS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$2.14

Target 3M

$2.4

Target 6M

$2.27

STXS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

STXS Price Action

Last 7 days

-9.4%

Last 30 days

8.3%

Last 90 days

-14.7%

Trailing 12 Months

8.3%

STXS RSI Chart

STXS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

STXS Valuation

Market Cap

232.4M

Price/Earnings (Trailing)

-9.84

Price/Sales (Trailing)

7.73

Price/Free Cashflow

-27.5

STXS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$2.14

Target 3M

$2.4

Target 6M

$2.27

STXS Fundamentals

STXS Revenue

Revenue (TTM)

30.1M

Rev. Growth (Yr)

-18.83%

Rev. Growth (Qtr)

-15.16%

STXS Earnings

Earnings (TTM)

-23.6M

Earnings Growth (Yr)

-4.41%

Earnings Growth (Qtr)

-68.92%

STXS Profitability

Operating Margin

53.07%

Return on Equity

-377.07%

Return on Assets

-51.83%

Free Cashflow Yield

-3.64%

STXS Investor Care

Shares Dilution (1Y)

10.14%

Diluted EPS (TTM)

-0.28

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202527.5M31.8M30.1M0
202427.1M23.7M25.1M26.9M
202327.7M29.4M29.5M26.8M
202233.4M30.5M29.1M28.1M
202129.5M33.2M33.6M35.0M
202027.6M26.2M26.7M26.6M
201929.0M28.6M29.3M28.9M
201830.5M029.9M29.3M
201730.5M31.1M30.9M31.1M
201636.8M35.0M34.1M32.2M
201536.2M37.8M38.2M37.7M
201438.0M36.3M34.3M35.0M
201342.7M41.9M41.2M38.0M
201244.0M43.0M46.0M46.6M
201153.7M50.2M44.9M42.0M
20100053.1M54.1M
Get all data in R, Python etc through our Historical Stock Data APIs

About Stereotaxis Inc

STXS
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.
 CEO
 WEBSITEstereotaxis.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES130

Stereotaxis Inc Frequently Asked Questions

STXS is the stock ticker symbol of Stereotaxis Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Stereotaxis Inc is 232.38 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check STXS's fair value in chart for subscribers.

The fair value guage provides a quick view whether STXS is over valued or under valued. Whether Stereotaxis Inc is cheap or expensive depends on the assumptions which impact Stereotaxis Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for STXS.

As of Wed Jan 28 2026, STXS's PE ratio (Price to Earnings) is -9.84 and Price to Sales (PS) ratio is 7.73. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. STXS PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Stereotaxis Inc has provided 0.139 (multiply by 100 for percentage) rate of return.